Heart Failure Clinical Trial
— PROTECTOfficial title:
Person-centred Care at Distance for Persons With Chronic Heart Failure (CHF) and/or Chronic Obstructive Pulmonary Disease (COPD)
Verified date | February 2020 |
Source | Göteborg University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of the research project PROTECT is to translate the Person-Centred Care (PCC) principles into an eHealth (the use of information and communication technologies for health) context. A developed PCC eHealth platform will be used as a tool to identify patients´ resources to enhance coping and living with their chronic illness by means of a dialog and partnership with staff and relatives. The PCC eHealth platform will not replace, but instead be used as add on treatment to usual care (guideline directed care).
Status | Active, not recruiting |
Enrollment | 224 |
Est. completion date | June 30, 2021 |
Est. primary completion date | February 12, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - National registration within the Västra Götaland Region (VGR) - Men and women listed at a primary care centre in Närhälsan with a history of confirmed diagnosis of COPD and /or CHF - Must understand written and spoken Swedish Exclusion Criteria: - Severe impairment that prevents patient from using the eHealth support - No registered address - Any severe disease with an expected survival < 12 months - Cognitive impairment (SPMSQ score >6) - Ongoing documented diagnosis of alcohol or drug abuse - Other disease that can interfere with follow-up (e.g. severe depression, other severe mental illness) - Patient participating in another conflicting randomized study |
Country | Name | City | State |
---|---|---|---|
Sweden | Primary health care | Gothenburg |
Lead Sponsor | Collaborator |
---|---|
Göteborg University |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Composite score of changes in general self-efficacy | The primary efficacy endpoint is a composite score of changes in general self-efficacy 18 based on the General Self-Efficacy Scale (GSE), hospitalization and death. The rationale for such an endpoint is the value of combining patient experience and clinical outcomes. A patient is classified as improved, deteriorated or unchanged: A patient is classified as deteriorated if any of the following occurred: · at 6 months, self-efficacy has decreased by > 5 units (the minimal change of clinical significance) or has been admitted to hospital for unscheduled reasons or died. A patient is classified as improved if: self-efficacy has increased by > 5 units and has not been hospitalized. Those who have neither deteriorated nor improved are considered unchanged. |
baseline, 3, 6, 12, 24 months | |
Secondary | Number of admissions | Number of admissions | 3, 6, 12, 24 months | |
Secondary | General self-efficacy scale | Questionnaire | 3,6,12,24 months | |
Secondary | Health care utilization | number of admissions and unscheduled outpatient visits due to unplanned visits to hospital and/or primary care centre due to symptoms of COPD and CHF | 3,6,12,24 months | |
Secondary | Incremental cost-utility ratios | Incremental cost-utility ratios | 3,6,12, 24 months | |
Secondary | Health-related quality of life (EQ-5D) | Questionnaire | 3,6,12,24 months | |
Secondary | Hospital anxiety and depression scale (HADS) | Questionnaire | 3,6,12,24 months | |
Secondary | Shortness of breath in heart failure (SOB-HF) | Questionnaire | 3,6,12,24 months | |
Secondary | COPD Assessment Test (CAT) | Questionnaire | 3,6,12,24 months | |
Secondary | The MRC breathlessness scale | Questionnaire | 3,6,12,24 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Active, not recruiting |
NCT05896904 -
Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction
|
N/A | |
Completed |
NCT05077293 -
Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
|
||
Recruiting |
NCT05631275 -
The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
|
||
Enrolling by invitation |
NCT05564572 -
Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology
|
N/A | |
Enrolling by invitation |
NCT05009706 -
Self-care in Older Frail Persons With Heart Failure Intervention
|
N/A | |
Recruiting |
NCT04177199 -
What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
|
||
Terminated |
NCT03615469 -
Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY)
|
N/A | |
Recruiting |
NCT06340048 -
Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure
|
Phase 1/Phase 2 | |
Recruiting |
NCT05679713 -
Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
|
||
Completed |
NCT04254328 -
The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure
|
N/A | |
Completed |
NCT03549169 -
Decision Making for the Management the Symptoms in Adults of Heart Failure
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05538611 -
Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
|
||
Recruiting |
NCT04262830 -
Cancer Therapy Effects on the Heart
|
||
Completed |
NCT06026683 -
Conduction System Stimulation to Avoid Left Ventricle Dysfunction
|
N/A | |
Withdrawn |
NCT03091998 -
Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support
|
Phase 1 | |
Recruiting |
NCT05564689 -
Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
|